arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Madrigal Pharmaceuticals, Inc.

MDGL Health Care Biotechnology: Pharmaceutical Preparations
$541.08
Today
as of Sep 4, 16:51 ET
Last 30 days +0.42% Jul 28 → Sep 04
$460.95 $484.04 $507.12 $530.21 $553.30 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$536.82
High
$547.92
Low
$536.43
Volume
$177,162
Avg Vol
$338,983
Mkt Cap
$11.7B
P/E (TTM)
—
Beta
—
52w High
$615.00
52w Low
$393.61
Div Yield
—
Shares Out
$23M

Recent Press Releases & News last 60 days · 25 items

Sep 2 · 12:00 PR GlobeNewswire
Madrigal Pharmaceuticals to Participate in the  2026 Cantor Global Healthcare Conference
Aug 25 · 16:20 Motley Fool
Here's Exactly What It Will Take for Madrigal Pharmaceuticals Stock to Take Off
Aug 20 · 20:05 PR GlobeNewswire
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
▸ Show all 25 press releases & news Free account →

Overview

52-week range
$394
$615
67% of range
Avg surprise (last 3)
+21.2%
Avg reaction (last 2)
+2.8%
50% positive
Latest IV / EM
40%
EM ±6.3% · $540 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-7.38$-6.01$-4.64$-3.27$-1.90 Actual $-4.23Actual $-4.69Actual $-5.34Actual $-7.38Actual $-7.10Actual $-4.92Actual $-3.32Est $-3.62Actual $-1.90Est $-3.48Actual $-4.01Actual $-3.25Est $-3.61Actual $-1.99 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-114M$10M$134M$258M$382M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.99 — — — — financials
Wed May 6, 2026Mar/2026 $-3.25 $-3.61 +10.0% +2.1% +7.4% earnings
Tue Sep 30, 2025Sep 2025 $-4.01 — — — — financials
Tue Aug 5, 2025Jun/2025 $-1.90 $-3.48 +45.4% — — earnings
Thu May 1, 2025Mar/2025 $-3.32 $-3.62 +8.3% — -1.9% earnings
Mon Sep 30, 2024Sep 2024 $-4.92 — — — — financials
Sun Jun 30, 2024Jun 2024 $-7.10 — — — — financials
Sun Mar 31, 2024Mar 2024 $-7.38 — — — — financials
Sat Sep 30, 2023Sep 2023 $-5.34 — — — — financials
Fri Jun 30, 2023Jun 2023 $-4.69 — — — — financials
Fri Mar 31, 2023Mar 2023 $-4.23 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$364M$311M—$287M$213M$137M—$62M
Cost of revenue—————$5M——
Gross profit————————
Operating income$-56M$-93M—$-114M$-47M$-79M—$-116M
Net income$-58M$-94M—$-114M$-42M$-73M—$-107M
EPS (diluted)$-1.99$-3.25—$-4.01$-1.50$-2.61—$-4.92

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$293M$227M$199M$296M$186M$184M$100M$233M
Inventory$99M$112M$75M$69M$63M$55M$34M$9M
Total current assets$1.20B$1.18B$1.25B$1.35B$1.00B$988M$1.03B$1.06B
Total assets$1.24B$1.23B$1.26B$1.36B$1.02B$997M$1.04B$1.07B
Long-term debt$341M$340M$340M$340M$118M$118M$118M$117M
Total liabilities$721M$684M$657M$737M$319M$286M$288M$296M
Total equity$524M$543M$603M$626M$696M$711M$754M$777M

Implied volatility — last 90 days

35%47%58%69%80% Jun 07 — IV 50% · EM ±7.0%Jun 08 — IV 52% · EM ±6.9%Jun 09 — IV 49% · EM ±6.2%Jun 10 — IV 44% · EM ±5.2%Jun 11 — IV 44% · EM ±4.8%Jun 12 — IV 42% · EM ±4.3%Jun 15 — IV 54% · EM ±3.9%Jun 16 — IV 54% · EM ±3.2%Jun 17 — IV 80% · EM ±3.4%Jun 19 — IV 48% · EM ±10.5%Jun 22 — IV 49% · EM ±10.3%Jun 23 — IV 50% · EM ±10.2%Jun 24 — IV 50% · EM ±10.0%Jun 25 — IV 47% · EM ±9.3%Jun 26 — IV 46% · EM ±8.8%Jun 29 — IV 46% · EM ±8.2%Jun 30 — IV 44% · EM ±7.5%Jul 01 — IV 46% · EM ±7.7%Jul 02 — IV 44% · EM ±7.1%Jul 03 — IV 45% · EM ±7.1%Jul 06 — IV 48% · EM ±6.6%Jul 07 — IV 45% · EM ±6.0%Jul 08 — IV 44% · EM ±5.5%Jul 09 — IV 44% · EM ±5.2%Jul 10 — IV 45% · EM ±4.9%Jul 13 — IV 50% · EM ±4.2%Jul 14 — IV 52% · EM ±3.7%Jul 15 — IV 46% · EM ±2.7%Jul 16 — IV 53% · EM ±2.2%Jul 20 — IV 59% · EM ±13.9%Jul 21 — IV 58% · EM ±13.5%Jul 22 — IV 58% · EM ±13.4%Jul 23 — IV 58% · EM ±13.1%Jul 24 — IV 58% · EM ±12.9%Jul 27 — IV 62% · EM ±12.9%Jul 28 — IV 61% · EM ±12.6%Jul 29 — IV 62% · EM ±12.4%Jul 30 — IV 44% · EM ±8.6%Jul 31 — IV 42% · EM ±8.1%Aug 03 — IV 45% · EM ±8.0%Aug 04 — IV 45% · EM ±7.7%Aug 05 — IV 44% · EM ±7.3%Aug 06 — IV 43% · EM ±6.9%Aug 07 — IV 40% · EM ±6.2%Aug 10 — IV 44% · EM ±6.1%Aug 11 — IV 42% · EM ±5.6%Aug 12 — IV 36% · EM ±4.5%Aug 13 — IV 42% · EM ±5.0%Aug 14 — IV 36% · EM ±4.0%Aug 17 — IV 42% · EM ±3.5%Aug 18 — IV 45% · EM ±3.2%Aug 19 — IV 45% · EM ±2.7%Aug 20 — IV 54% · EM ±2.3%Aug 24 — IV 39% · EM ±8.2%Aug 25 — IV 40% · EM ±8.2%Aug 26 — IV 42% · EM ±8.4%Aug 27 — IV 43% · EM ±8.5%Aug 28 — IV 43% · EM ±8.2%Aug 31 — IV 47% · EM ±8.3%Sep 01 — IV 45% · EM ±7.8%Sep 02 — IV 41% · EM ±6.9%Sep 03 — IV 42% · EM ±6.7%Sep 04 — IV 40% · EM ±6.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in